Cargando…

Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies

Background: Disease-modifying therapies (DMTs) used to treat multiple sclerosis (MS) alter the immune system and therefore increase the risk of infection. There is growing concern about the impact of COVID-19 on patients with MS (pwMS), especially those treated with DMTs. Methods: This is a single-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sancho-Saldaña, Agustín, Gil Sánchez, Anna, Quirant-Sánchez, Bibiana, Nogueras, Lara, Peralta, Silvia, Solana, Maria José, González-Mingot, Cristina, Gallego, Yhovanni, Quibus, Laura, Ramo-Tello, Cristina, Presas-Rodríguez, Silvia, Martínez-Cáceres, Eva, Torres, Pascual, Hervás, José Vicente, Valls, Joan, Brieva, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099725/ https://www.ncbi.nlm.nih.gov/pubmed/35566632 http://dx.doi.org/10.3390/jcm11092509

Ejemplares similares

A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies
por: Torres, Pascual, et al.
Publicado: (2023)

Optimal response to dimethyl fumarate is mediated by a reduction of Th1‐like Th17 cells after 3 months of treatment
por: Mansilla, María José, et al.
Publicado: (2019)

Th1Th17(CM) Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment
por: Quirant-Sánchez, Bibiana, et al.
Publicado: (2019)

Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis
por: Quirant-Sánchez, Bibiana, et al.
Publicado: (2021)

MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients
por: Navarro-Barriuso, Juan, et al.
Publicado: (2019)

Vitamin D3-Induced Tolerogenic Dendritic Cells Modulate the Transcriptomic Profile of T CD4(+) Cells Towards a Functional Hyporesponsiveness
por: Navarro-Barriuso, Juan, et al.
Publicado: (2021)

Preventive treatment can reverse cognitive impairment in chronic migraine
por: González-Mingot, Cristina, et al.
Publicado: (2022)

Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients
por: Gonzalo, Hugo, et al.
Publicado: (2019)

Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycin
por: Navarro-Barriuso, Juan, et al.
Publicado: (2018)

Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis
por: Nogueras, L., et al.
Publicado: (2019)

Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers
por: Ortega-Hernandez, Oscar-Danilo, et al.
Publicado: (2023)

Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab
por: Granell-Geli, Júlia, et al.
Publicado: (2021)

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses
por: Ramo-Tello, Cristina, et al.
Publicado: (2021)

Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy
por: Mansilla, M. J., et al.
Publicado: (2021)

Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study
por: González Mingot, Cristina, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave
por: Barallat, Jaume, et al.
Publicado: (2020)

Mitochondrial Aconitase Enzymatic Activity: A Potential Long-Term Survival Biomarker in the Blood of ALS Patients
por: González-Mingot, Cristina, et al.
Publicado: (2023)

SARS-CoV-2: una nueva amenaza
por: López Rodríguez, Cristina A., et al.
Publicado: (2020)

SARS-CoV-2: a new threat
por: López Rodríguez, Cristina A., et al.
Publicado: (2020)

HLA-DR Expression on Monocytes and Sepsis Index Are Useful in Predicting Sepsis
por: Quirant-Sánchez, Bibiana, et al.
Publicado: (2023)

Personalized Diagnosis and Therapy for Multiple Sclerosis
por: Ramo-Tello, Cristina
Publicado: (2022)

Heart–Lung–Muscle Anti-SAE Syndrome: An Atypical Severe Combination
por: Zamora, Elisabet, et al.
Publicado: (2018)

Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change
por: Zuluaga, Paola, et al.
Publicado: (2022)

Identifying Changes in Peripheral Lymphocyte Subpopulations in Adult Onset Type 1 Diabetes
por: Teniente-Serra, Aina, et al.
Publicado: (2021)

Transfection of Vitamin D3-Induced Tolerogenic Dendritic Cells for the Silencing of Potential Tolerogenic Genes. Identification of CSF1R-CSF1 Signaling as a Glycolytic Regulator
por: Mansilla, María José, et al.
Publicado: (2021)

Cryopreserved vitamin D(3)-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients
por: Mansilla, María José, et al.
Publicado: (2016)

Tolerogenic dendritic cells in experimental autoimmune encephalomyelitis, specific tolerance induction?
por: Sellés-Moreno, Carla, et al.
Publicado: (2012)

Seroprevalence of Bartonella spp. infection in HIV patients in Catalonia, Spain
por: Pons, Immaculada, et al.
Publicado: (2008)

Follow up of the Humoral Response in Healthcare Workers after the Administration of Two Dose of the Anti SARS-CoV-2 Vaccines—Effectiveness in Delta Variant Breakthrough Infections
por: Fernández-Rivas, Gema, et al.
Publicado: (2022)

Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration
por: Willekens, Barbara, et al.
Publicado: (2019)

Immunological Pattern in IgA Nephropathy
por: Esteve Cols, Clara, et al.
Publicado: (2020)

Trypanosoma cruzi: Seroprevalence Detection in Suburban Population of Santiago de Querétaro (Mexico)
por: López-Céspedes, Ángeles, et al.
Publicado: (2012)

Diagnostic value of different anti-citrullinated peptides antibodies in rheumatoid arthritis
por: Ruiz-Ortiz de Arrizabaleta, Estíbaliz, et al.
Publicado: (2011)

SARS-CoV-2 Seroprevalence Studies in Pets, Spain
por: Barroso-Arévalo, Sandra, et al.
Publicado: (2023)

Characterization of recent thymic emigrants (RTEs), transitional B and Th17 cells in multiple sclerosis (MS)
por: Teniente-Serra, Aina, et al.
Publicado: (2011)

Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients
por: Grau-López, Laia, et al.
Publicado: (2012)

La anemia aumenta el riesgo de mortalidad debido a fragilidad y discapacidad en mayores: Estudio FRADEA
por: Esquinas-Requena, José Luis, et al.
Publicado: (2020)

A retrospective study of SARS-CoV-2 seroprevalence in dogs and cats in the Community of Madrid, Spain
por: Sánchez-Morales, Lidia, et al.
Publicado: (2023)

Ulcerative Colitis and Crohn’s Disease Are Associated with Decreased Serum Selenium Concentrations and Increased Cardiovascular Risk
por: Castro Aguilar-Tablada, Teresa, et al.
Publicado: (2016)

Cutaneous Leishmaniasis in dogs: is high seroprevalence indicative of a reservoir role?
por: CALZADA, JOSÉ E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hdocpd7qo2t1ndb9dg4p40ltic